Schuster D - Search Results

1

The discovery of new 11beta-hydroxysteroid dehydrogenase type 1 inhibitors by common feature pharmacophore modeling and virtual screening.

Schuster D, Maurer EM, Laggner C, Nashev LG, Wilckens T, Langer T, Odermatt A. Schuster D, et al. J Med Chem. 2006 Jun 15;49(12):3454-66. doi: 10.1021/jm0600794. J Med Chem. 2006. PMID: 16759088

2

The identification of ligand features essential for PXR activation by pharmacophore modeling.

Schuster D, Langer T. Schuster D, et al. J Chem Inf Model. 2005 Mar-Apr;45(2):431-9. doi: 10.1021/ci049722q. J Chem Inf Model. 2005. PMID: 15807509

3

Comparative enzymology of 11beta-hydroxysteroid dehydrogenase type 1 from six species.

Arampatzis S, Kadereit B, Schuster D, Balazs Z, Schweizer RA, Frey FJ, Langer T, Odermatt A. Arampatzis S, et al. Among authors: schuster d. J Mol Endocrinol. 2005 Aug;35(1):89-101. doi: 10.1677/jme.1.01736. J Mol Endocrinol. 2005. PMID: 16087724

4

Synthesis and pharmacological evaluation of 1H-imidazoles as ligands for the estrogen receptor and cytotoxic inhibitors of the cyclooxygenase.

Wiglenda T, Ott I, Kircher B, Schumacher P, Schuster D, Langer T, Gust R. Wiglenda T, et al. Among authors: schuster d. J Med Chem. 2005 Oct 6;48(20):6516-21. doi: 10.1021/jm050190u. J Med Chem. 2005. PMID: 16190777

5

Why drugs fail--a study on side effects in new chemical entities.

Schuster D, Laggner C, Langer T. Schuster D, et al. Curr Pharm Des. 2005;11(27):3545-59. doi: 10.2174/138161205774414510. Curr Pharm Des. 2005. PMID: 16248807 Review.

6

Why is 11beta-hydroxysteroid dehydrogenase type 1 facing the endoplasmic reticulum lumen? Physiological relevance of the membrane topology of 11beta-HSD1.

Odermatt A, Atanasov AG, Balazs Z, Schweizer RA, Nashev LG, Schuster D, Langer T. Odermatt A, et al. Among authors: schuster d. Mol Cell Endocrinol. 2006 Mar 27;248(1-2):15-23. doi: 10.1016/j.mce.2005.11.040. Epub 2006 Jan 10. Mol Cell Endocrinol. 2006. PMID: 16412558 Review.

7

Pharmacophore modeling and in silico screening for new P450 19 (aromatase) inhibitors.

Schuster D, Laggner C, Steindl TM, Palusczak A, Hartmann RW, Langer T. Schuster D, et al. J Chem Inf Model. 2006 May-Jun;46(3):1301-11. doi: 10.1021/ci050237k. J Chem Inf Model. 2006. PMID: 16711749

8

Development and validation of an in silico P450 profiler based on pharmacophore models.

Schuster D, Laggner C, Steindl TM, Langer T. Schuster D, et al. Curr Drug Discov Technol. 2006 Mar;3(1):1-48. doi: 10.2174/157016306776637609. Curr Drug Discov Technol. 2006. PMID: 16712462

9

Predicting drug metabolism induction in silico.

Schuster D, Steindl TM, Langer T. Schuster D, et al. Curr Top Med Chem. 2006;6(15):1627-40. doi: 10.2174/156802606778108924. Curr Top Med Chem. 2006. PMID: 16918474 Review.

10

Taspine: bioactivity-guided isolation and molecular ligand-target insight of a potent acetylcholinesterase inhibitor from Magnolia x soulangiana.

Rollinger JM, Schuster D, Baier E, Ellmerer EP, Langer T, Stuppner H. Rollinger JM, et al. Among authors: schuster d. J Nat Prod. 2006 Sep;69(9):1341-6. doi: 10.1021/np060268p. J Nat Prod. 2006. PMID: 16989531 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

914 results

Search Page

Filters